Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Portfolio Pulse from Lisa Levin
Beyond Air, Inc. (XAIR) shares dropped by 37.3% to $1.2701 due to weaker than expected quarterly results, with a loss of 51 cents per share and sales of $239,000 against expectations of $480,000. Other stocks experienced significant movements in Tuesday's mid-day session, with notable gainers including BioCardia, Inc. (BCDA), reAlpha Tech Corp. (AIRE), and Theseus Pharmaceuticals, Inc. (THRX), among others. Losers included Li-Cycle Holdings Corp. (LICY) and The Beauty Health Company (SKIN), which both saw sharp declines after reporting disappointing financial results.

November 14, 2023 | 7:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Li-Cycle Holdings Corp. shares fell sharply after reporting third-quarter financial results that disappointed investors.
The drastic decline in Li-Cycle's stock price is attributed to its reported financial results, which likely raised concerns about the company's profitability and growth prospects.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
The Beauty Health Company's stock plummeted after weaker-than-expected financial results for its third quarter and a revision of its sales outlook.
The Beauty Health Company's stock price drop is a direct reaction to its poor earnings report and lowered future sales expectations, which are negative indicators for investors.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Beyond Air's stock plummeted due to reporting a larger loss and lower sales than expected in its quarterly results.
The significant drop in Beyond Air's stock price is directly related to its reported earnings missing analysts' expectations, which is a strong negative signal to investors.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
BioCardia's stock surged after the FDA approved its Phase 3 clinical trial for a heart failure cell therapy treatment.
BioCardia's significant stock price increase is a result of positive regulatory news, which typically leads to increased investor confidence and potential future revenue growth.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100